Drug intelligence / Profile preview

Sufei Pingchuan Decoction

Development stage: Unknown
Lead developer: Xiyuan Hospital
Administration: Oral

Overview

Sufei Pingchuan Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Xiyuan Hospital of the Chinese Academy of Chinese Medical Sciences. It is primarily investigated for the treatment of bronchiectasis, specifically in patients presenting with airflow limitation. As a decoction, it is a liquid preparation made by boiling various Chinese medicinal herbs, designed to 'clear the lungs' and 'relieve wheezing' (asthma) according to TCM principles. The formula is currently being evaluated in clinical research, such as trial ChiCTR2200057025, to assess its efficacy in improving lung function parameters like FEV1 and alleviating clinical symptoms in affected individuals.

Other names: Sufei Pingchuan Tang肃肺平喘汤

Beyond the preview

Go deeper on Sufei Pingchuan Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sufei Pingchuan Decoction.

Explore the full profile